Lyme disease;Enfermedad de Lyme

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 32, Issue SUPPL.1, 2014, Pages 37-42

  Portillo, Aránzazu ^a   Santibáñez, Sonia ^a   Oteo, José A ^a  

^a CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

Author keywords

Borrelia burgdorferi sensu lato; Ixodes ricinus; Lyme disease; Spain

Indexed keywords

ARTICLE; BORRELIA BURGDORFERI; BORRELIA GARINII; ERYTHEMA CHRONICUM MIGRANS; HUMAN; IXODES RICINUS; LYME DISEASE; NONHUMAN;

HUMANS; LYME DISEASE;

EID: 84896361542     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(14)70148-X     Document Type: Article

References (51)

1. Stanek G, O'Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granström M, et al. European Union concerted action on risk assessment in Lyme borreliosis: Clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr. 1996;108:741-7.
2. Steere AC. Lyme disease. N Engl J Med. 2001;345:115-25.
3. Oteo Revuelta JA, Blanco JR, Ibarra Cucalón V. Enfermedad De Lyme y otras borreliosis. Medicine. 2002;8:3693-700.
4. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;17:69-79.
5. Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, et al. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1977;20:7-17.
6. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease-A tick-borne spirochetosis Science. 1982;216:1317-9.
7. Feder HM, Johnson BJB, O'Connell S, Shapiro ED, Steere AC, Wormser GP, et al. A critical appraisal of "chronic Lyme disease". N Engl J Med. 2007;357:1422-30.
8. Branda JA, Strle F, Strle K, Sikand N, Ferraro MJ, Steere AC. Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe. Clin Infect Dis. 2013;57:333-40.
9. Shoen RT. Better laboratory testing for Lyme disease: No more Western Blot. Clin Infec Dis. 2013;57:341-3.
10. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease. Dissociation of specific T-and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med. 1988;319:1441-6.
11. Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoërsdorff A, Blanco JR, et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect. 2004;10:1108-32.
12. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-134.
13. Disponible en: Http://www.cdc.gov/spanish/niosh/topics/LymeDisease-sp. html
14. European Union Concerted Action on Lyme borreliosis (EUCALB). 2008.
15. Mygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17:8-16.
16. Stanek G, Reiter M. The expanding Lyme Borrelia complex-clinical significance of genomic species Clin Microbiol Infect. 2011;17:487-93.
17. Oteo JA, Portillo A. Tick-borne rickettsioses in Europe. Ticks Tick Borne Dis. 2012;3:271-8.
18. Oteo JA, Backenson PB, Del Mar Vitutia M, García Moncó JC, Rodríguez I, Escudero R, et al. Use of the C3H/He Lyme disease mouse model for the recovery of a Spanish isolate of Borrelia garinii from erythema migrans lesions. Res Microbiol. 1998;149:39-46.
19. Oteo-Revuelta JA, Martínez De Artola V. Borreliosis De Lyme: Aspectos epidemiológicos y etiopatogénicos. Enferm Infecc Microbiol Clin. 1995;13:550-5.
20. Medlock JM, Hansford KM, Bormane A, Derdakova M, Estrada-Peña A, George JC, et al. Driving forces for changes in geographical distribution of Ixodes ricinus ticks in Europe. Parasit Vectors. 2013;6:1.
21. Parola P, Socolovschi C, Jeanjean L, Bitam I, Fournier PE, Sotto A, et al. Warmer weather linked to tick attack and emergence of severe rickettsioses. PLoS Negl Trop Dis. 2008;2:e338.
22. Palomar AM, Santibáñez P, Mazuelas D, Roncero L, Santibáñez S, Portillo A, et al. Role of birds in dispersal of etiologic agents of tick-borne zoonoses, Spain, 2009. Emerg Infect Dis. 2012;18:1188-91.
23. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461-73.
24. Hidri N, Barraud O, De Martino S, Garnier F, Paraf F, Martin C, et al. Lyme endocarditis. Clin Microbiol Infect. 2012;18:E531-2.
25. Nadelman RB, Wormser GP. Reinfection versus relapse in Lyme disease. N Engl J Med. 2013;368:1063-4.
26. Steere AC. Reinfection versus relapse in Lyme disease. N Engl J Med. 2013;368:1064.
27. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005;18:484-509.
28. Glatz M, Golestani M, Kerl H, Müllegger RR. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: Long-term follow-up study of 113 patients. Arch Dermatol. 2006;142:862-8.
29. Preac-Mursic V, Wilske B, Reinhardt S. Culture of Borrelia burgdorferi on six solid media. Eur J Clin Microbiol Infect Dis. 1991;10:1076-9.
30. Wilske B, Schriefer M. Borrelia. En: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of Clinical Microbiology. Washington, DC: ASM Press; 2003. p. 937-54.
31. Wilske B. Diagnosis of Lyme borreliosis in Europe. Vector Borne Zoonotic Dis. 2013;3:215-27.
32. Pereyra-Rodríguez JJ, Bernabeu-Wittel J, Cañas E, Julián Conejo-Mir J. Mácula eritematosa lentamente progresiva. Enferm Infecc Microbiol Clin. 2011;29:68-9.
33. Eshoo MW, Crowder CC, Rebman AW, Rounds MA, Matthews HE, Picuri JM, et al. Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease. PLoS One. 2012;7:e36825.
34. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995;44:590-1.
35. Oteo JA, Martínez De Artola V, Casas JM, Estrada Peña A. Lyme disease in La Rioja. Med Clin (Barc). 1991;96:599.
36. Seriburi V, Ndukwe N, Chang Z, Cox ME, Wormser GP. High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect. 2012;18:1236-40.
37. Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay. Clin Infect Dis. 2011;53:541-7.
38. Portillo A, Chaparro E, Oteo JA, Jado I, Anda P, Escudero R. Evaluación De dos ensayos comerciales para el diagnóstico serológico De La borreliosis De Lyme. Congreso De La Sociedad Española De Enfermedades Infecciosas y Microbiología Clínica. Valencia, 10-13 Mayo 2006.
39. Cinco M, Murgia R. Evaluation of the C6 enzyme-linked immunoadsorbent assay for the serodiagnosis of Lyme borreliosis in north-eastern Italy. New Microbiol. 2006;29:139-41.
40. Klempner MS, Schmid CH, Hu L, Steere AC, Johnson G, McCloud B, et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med. 2001;110:217-9.
41. Kalish RS, Wood JA, Golde W, Bernard R, Davis LE, Grimson RC, et al. Human T lymphocite response to Borrelia burgdorferi infection: No correlation between human leukocyte function antigen type 1 peptide response and clinical status. J Infect Dis. 2003;187:102-8.
42. Notice to readers: Caution regarding testing for Lyme disease. MMWR CDC Surveill Summ. 2005;54:125.
43. Rauter C, Mueller M, Diterich I, Zeller S, Hassler D, Meergans T, et al. Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis. Clin Diagn Lab Immunol. 2005;12:910-7.
44. Marques A, Brown MR, Fleisher TA. Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls. Clin Vaccine Immunol. 2009;16:1249-50.
45. Ettestad PJ, Campbell GL, Welbel SF, Genese CA, Spitalny KC, Marchetti CM, et al. Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis. 1995;171:356-61.
46. Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM. Death from inappropriate therapy for Lyme disease. Clin Infect Dis. 2000;31:1107-9.
47. Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, et al. Study and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trial. Neurology. 2003;60:1923-30.
48. Wormser GP, Dattwyler RJ, Shapiro E, Halperin JJ, Steere AC, Klempner MS, et al. Reply to Pollack, Donta, Wilson and Arnez. Clin Infect Dis. 2007;44:1137-9.
49. García-Álvarez L, Oteo JA. Efectos no antimicrobianos De las tetraciclinas. Rev Esp Quimioter. 2010;23:4-11.
50. Stupica D, Lusa L, Ruzić-Sabljić E, Cerar T, Strle F. Treatment of erythema migrans with doxycycline for 10 days versus 15 days. Clin Infect Dis. 2012;55:343-50.
51. Oteo JA, Blanco JR, Ibarra V. ¿Podemos prevenir las enfermedades transmitidas por garrapatas Enferm Infecc Microbiol Clin. 2001;19:509-13.